Codelac BRONCHO
Active material: Combined medication for the treatment of cough
When ATH: R05CA10
CCF: The drug with mucolytic, expectorant and anti-inflammatory action
ICD-10 codes (testimony): J15, J20, J42, J44, J47
When CSF: 12.02.02.01.01
Manufacturer: OAO Pharmstandard-Leksredstva (Russia)
Pharmaceutical form, composition and packaging
◊ Pills from light cream to cream to yellowish white in color with darker and lighter patches, Valium, risks and chamfer.
1 tab. | |
ambroxol hydrochloride | 20 mg |
sodium glycyrrhizinate | 30 mg |
dry extract Thermopsis | 10 mg |
natriya carbonate | 200 mg |
Excipients: potato starch, microcrystalline cellulose, povidone K25 (Kollidon K25), talc, stearic acid, sodium carboxymethyl starch (sodium starch glycolate, primodzhel).
10 PC. – packings Valium planimetric (1) – packs cardboard.
10 PC. – packings Valium planimetric (2) – packs cardboard.
Pharmacological action
Combined medication for the treatment of cough, It has mucolytic and expectorant action, and also has anti-inflammatory activity. Action Codelac® Broncho pharmacological properties due to its components.
Ambroxol has sekretomotornym, sekretoliticheskim and expectorant, normalizes impaired ratio of serous and mucous components of sputum, increases the secretion of surfactant in the alveoli. It reduces the viscosity of mucus and contributes to its discharge of.
Glicirrat (Glycyrrhizic acid and its salts) anti-inflammatory and antiviral action. It has a cytoprotective effect due to the antioxidant and membrane stabilizing activity. Potentiates the action of endogenous corticosteroids, providing anti-inflammatory and anti-allergic effect. Due pronounced antiinflammatory activity, reduces inflammation in the airways.
The extract has expectorant action Thermopsis, exerting mild irritant effect on the receptors of the gastric mucosa, reflexively increases the secretion of bronchial glands.
Sodium bicarbonate pH shifts bronchial mucus in the alkaline side, reduces the viscosity of sputum, It stimulates the motor function of the ciliated epithelium and bronchioles.
Pharmacokinetics
Data on the pharmacokinetics Codelac® Broncho not provided.
Testimony
Diseases of the respiratory tract with obstruction of sputum discharge:
- Acute and chronic bronchitis;
- Pneumonia;
- COPD;
- Bronchiectasis.
Dosage regimen
The drug is taken orally during meals.
Adults and children over 12 years appoint 1 tablet 3 times / day.
Do not use the drug more 4-5 days without a doctor's prescription.
Side effect
CNS: rarely – weakness, headache.
From the digestive system: rarely – diarrhea, dry mouth, constipation; Chronic administration of high doses – gastralgia, nausea, vomiting.
The respiratory system: rarely – dry mucous membranes of the respiratory tract, rhinorrhea.
Other: rarely – dizurija, rash, allergic reactions.
Contraindications
- Pregnancy;
- Lactation;
- Children up to age 12 years;
- Hypersensitivity to the drug.
FROM caution It is used in patients with hepatic and / or renal insufficiency, gastric ulcer and duodenal ulcer, asthmatic.
Pregnancy and lactation
The drug Codelac® Broncho is contraindicated in pregnancy and lactation (breast-feeding).
Cautions
Do not combine with antitussives.
Overdose
Symptoms: nausea, vomiting, diarrhea, dyspepsia.
Treatment: gastric lavage is advisable in the first 1-2 h after dosing; symptomatic therapy.
Drug Interactions
Joint application with antitussive drugs leads to difficulty sputum discharge on the background to reduce coughing.
The drug increases the penetration of the bronchial secretion of antibiotics.
Conditions of supply of pharmacies
The drug is resolved to application as an agent Valium holidays.
Conditions and terms
The drug should be stored out of reach of children, dark place at a temperature no higher than 25 ° C. Shelf life – 2 year.